Skip to main navigation Skip to search Skip to main content

Population differences and the effect of vaginal progesterone on preterm birth in women with threatened preterm labor*

  • Frederik Hermans (Creator)
  • Ariel Karolinski (Creator)
  • Véronique Othenin-Girard (Creator)
  • María Victoria Bertolino (Creator)
  • Ewoud Schuit (Creator)
  • Pablo Salgado (Creator)
  • Irene Hoesli (Creator)
  • Olivier Irion (Creator)
  • Cristina Laterra (Creator)
  • Ben Willem J. Mol (University of Adelaide, South Australian Health And Medical Research Institute) (Creator)
  • Begoña Martinez de Tejada (Contributor)

Dataset

Description

Objective: Threatened preterm labor (tPTL) is a complication of pregnancy. Identification of women and clinical definition differs between countries. This study investigated differences in tPTL and effectiveness of vaginal progesterone to prevent preterm birth (PTB) between two countries. Methods: Secondary analysis of a randomized controlled trial (RCT) from Argentina and Switzerland comparing vaginal progesterone to placebo in women with tPTL (n = 379). Cox proportional hazards analysis was performed to compare placebo groups of both countries and to compare progesterone to placebo within each country. We adjusted for baseline differences. Iatrogenic onset of labor or pregnancy beyond gestational age of interest was censored. Results: Swiss and Argentinian women were different on baseline. Risks for delivery
Date made available2016
PublisherTaylor & Francis

Cite this